| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | agomelatine (Valdoxan®) |
| Formulation | 25 mg film-coated tablet |
| Reference number | 13 |
| Indication | Treatment of major depressive episodes in adults |
| Company | Servier Laboratories Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 12/06/2008 |